insulin-dependent diabetes type 1 diabetes
Conditions
Interventions
biomarkers
heterogeneity
precision medicine
type 1 diabetes
Sponsors
Diabeter
Eligibility
Age
12 Years to 64 Years
Inclusion criteria
Inclusion criteria: 1. Type 1 diabetes determined by either autoantibodies or based on clinical and historical data, or both 2. At least 5 years of type 1 diabetes 3. Minimum age 16 years 4. Treated for type 1 diabetes at a diabetes center 5. Given informed consent by subject
Exclusion criteria
Exclusion criteria: 1. Non-type 1 diabetes 2. Patients with duration of type 1 diabetes below 5 years 3. Patients under the age of 16 years 4. Pregnancy or breastfeeding, until 3 months (12 weeks) after childbirth or breastfeeding 5. On experimental medication or participating in other studies with conflicting goals and schedules 6. Diseases or conditions that the investigator/physician believes to be a contraindication to participate 7. Unwilling to be informed on incidental findings
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| This biomarker research project intends to gain insight in the heterogeneity of type 1 diabetes en and to gather knowledge on the cause, development and treatment of the disease. | — |
Secondary
| Measure | Time frame |
|---|---|
| - | — |
Countries
The Netherlands
Outcome results
None listed